Recent News

• 03.16.2026 - NeoGenomics’ PanTracer LBx Receives Medicare Coverage, Expanding Access to Comprehensive Liquid Biopsy Profiling
• 02.25.2026 - NeoGenomics Launches RaDaR ST, Expanding Molecular Residual Disease Testing Across Multiple Solid Tumor Types
• 02.18.2026 - NeoGenomics to Participate in Upcoming Investor Conferences
• 02.17.2026 - NeoGenomics Reports Fourth Quarter and Full Year 2025 Results
• 02.12.2026 - NeoGenomics Introduces PanTracer Pro to Support Timely, Informed Solid Tumor Therapy Selection
• 01.27.2026 - NeoGenomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026

Recent Filings

• 03.03.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.03.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.03.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.03.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.02.2026 - 3 Initial statement of beneficial ownership of securities
• 02.24.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.24.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.24.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.24.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.17.2026 - 8-K Current report